Purva Bali

4.8k citations

41 papers · 3.9k indexed · 1 hit paper · h-index 24

Hematology top 1%
- Chronic Myeloid Leukemia Treatments 8
- Acute Myeloid Leukemia Research 6
Molecular Biology top 2%
- Histone Deacetylase Inhibitors Research 13
- Ubiquitin and proteasome pathways 6
- Heat shock proteins research 5
- Cell death mechanisms and regulation 4
Cancer Research top 5%
- MicroRNA in disease regulation 4
Developmental Neuroscience top 5%
Genetics top 5%
- Chronic Lymphocytic Leukemia Research 6

Co-authors: Kapil N. Bhalla Fei Guo Peter Atadja Paul J. Kenny Warren Fiskus Heh‐In Im Jonathan A. Hollander Maria E. Balasis
Cited by: Hematology Molecular Biology Cancer Research
Partner nations: United States Switzerland India

In The Last Decade

Purva Bali

39 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2005 Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90

Peers

Countries citing papers authored by Purva Bali

Since Specialization

Citations

This map shows the geographic impact of Purva Bali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Purva Bali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Purva Bali more than expected).

Fields of papers citing papers by Purva Bali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Purva Bali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Purva Bali. The network helps show where Purva Bali may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Purva Bali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Purva Bali Line = papers co-authored together Purva Bali links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Hedgehog-interacting protein acts in the habenula to regulate nicotine intake Stephanie P. B. Caligiuri,William M. Howe,Lauren Wills,Alexander C.W. Smith,Lei Ye,Purva Bali,Mary P. Heyer,Janna K. Moen,Jessica L. Ables,Karim S. Elayouby,Maya Williams,Clémentine Fillinger,Zainab Oketokoun,Vanessa E. Lehmann,Alexandra G. DiFeliceantonio,Paul M. Johnson,Kristin G. Beaumont,Robert Sebra,Inés Ibáñez-Tallon,Paul J. Kenny	2022	5
2	An increase in VGF expression through a rapid, transcription-independent, autofeedback mechanism improves cognitive function Wei‐Jye Lin,Yan Zhao,Zhe Li,Shuyu Zheng,Jinlin Zou,Noël A. Warren,Purva Bali,Jingru Wu,Mengdan Xing,Cheng Jiang,Yamei Tang,Stephen R. Salton,Xiaojing Ye	2021	20
3	Transcriptional mechanisms of drug addiction Purva Bali,Paul J. Kenny	2019	21
4	MicroRNAs and Drug Addiction Purva Bali,Paul J. Kenny	2013	53
5	Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists Rong Jiang,Xinyi Song,Purva Bali,Anthony M. Smith,Claudia Ruiz Bayona,Li Lin,Michael D. Cameron,Patricia McDonald,Paul J. Kenny,Theodore M. Kamenecka	2012	20
6	Methylation, memory and addiction Purva Bali,Heh‐In Im,Paul J. Kenny	2011	29
7	Striatal microRNA controls cocaine intake through CREB signalling Jonathan A. Hollander,Heh‐In Im,Antonio L. Amelio,Jannet Kocerha,Purva Bali,Qun Lu,David Willoughby,Claes Wahlestedt,Michael D. Conkright,Paul J. Kenny	2010	322
8	MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212 Heh‐In Im,Jonathan A. Hollander,Purva Bali,Paul J. Kenny	2010	356
9	Cotreatment with Vorinostat (Suberoylanilide Hydroxamic Acid) Enhances Activity of Dasatinib (BMS-354825) against Imatinib Mesylate–Sensitive or Imatinib Mesylate–Resistant Chronic Myelogenous Leukemia Cells Warren Fiskus,Michael Pranpat,Maria E. Balasis,Purva Bali,Verónica Estrella,Sandhya Kumaraswamy,Rekha Rao,Kathy Rocha,Bryan Herger,Francis Lee,Victoria M. Richon,Kapil N. Bhalla	2006	81
10	Activity of Suberoylanilide Hydroxamic Acid Against Human Breast Cancer Cells with Amplification of Her-2 Purva Bali,Michael Pranpat,Ramona F. Swaby,Warren Fiskus,Hirohito Yamaguchi,Maria E. Balasis,Kathy Rocha,Hong‐Gang Wang,Victoria M. Richon,Kapil N. Bhalla	2005	156
11	Germ cell-specific localization of immunoreactive riboflavin carrier protein in the male golden hamster: appearance during spermatogenesis and role in sperm function Arun Sreekumar,Kshitish K. Acharya,H S Lalitha,S. S. Indi,Purva Bali,Polani B. Seshagiri	2005	2
12	Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90breakdown → Purva Bali,Michael Pranpat,James E. Bradner,Maria E. Balasis,Warren Fiskus,Fei Guo,Kathy Rocha,Sandhya Kumaraswamy,Sandhya Boyapalle,Peter Atadja,Edward Seto,Kapil N. Bhalla	2005	644
13	Co-Treatment with a Novel Heat Shock Protein (hsp) 90 Inhibitor IPI504 and the Histone Deacetylase Inhibitor (HDI) Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA): A Highly Active Combination Against Wild Type or Mutant Bcr-Abl-T315I or FLT-3-ITD-Containing Human Leukemia Cells. Warren Fiskus,Purva Bali,Michael Pranpat,Maria E. Balasis,Sandhya Kumaraswamy,Sandhya Boyapalle,Kathy Rocha,Jeffery Tong,Victoria M. Richon,Emmanuel Normant,Kapil N. Bhalla	2005	1
14	Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824 Liwei Chen,Songshu Meng,Hai Wang,Purva Bali,Wenlong Bai,Benyi Li,Peter Atadja,Kapil N. Bhalla,Jie Wu	2005	76
15	Molecular Characterization of Human CML Cells with Resistance to the Heat Shock Protein (hsp) 90 Inhibitor 17-Allylamino-Demethoxy Geldanamycin (17-AAG). Purva Bali,Warren Fiskus,Fei Guo,Srinivas Annavarapu,Celia Sigua,Gautam Sondarva,Abdelmoughite Mouttaki,Peter Atadja,Paul W. Manley,Kapil N. Bhalla	2004	1
16	Superior Activity of the Combination of Histone Deacetylase Inhibitor LAQ824 and the FLT-3 Kinase Inhibitor PKC412 against Human Acute Myelogenous Leukemia Cells with Mutant FLT-3 Purva Bali,Prince George,Pamela Cohen,Jianguo Tao,Fei Guo,Celia Sigua,Anasuya Vishvanath,Anna Scuto,Srinivas Annavarapu,Warren Fiskus,Lynn C. Moscinski,Peter Atadja,Kapil N. Bhalla	2004	114
17	Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cells David Griffin,Sylvie Wittmann,Fei Guo,Ramadevi Nimmanapalli,Purva Bali,Hong‐Gang Wang,Kapil N. Bhalla	2003	28
18	Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B. Lianne Fuino,Purva Bali,Sylvie Wittmann,Sreenivas Donapaty,Fei Guo,Hirohito Yamaguchi,Hong‐Gang Wang,Peter Atadja,Kapil N. Bhalla	2003	228
19	Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative–(BMS 247550) and Apo-2L/TRAIL–induced apoptosis Fei Guo,Ramadevi Nimmanapalli,Shanthi R. Paranawithana,Sylvie Wittman,David Griffin,Purva Bali,Erica O’Bryan,Carlos Fumero,Hong‐Gang Wang,Kapil N. Bhalla	2002	136
20	Developmental and hormonal regulation of type II DNA topoisomerase in rat testis Rahul P. Bakshi,Sanjeev Galande,Purva Bali,Rajan R. Dighe,K. Muniyappa	2001	21

About Purva Bali

Purva Bali is a scholar working on Hematology, Genetics and Developmental Neuroscience, having authored 41 papers that have together received 3.9k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (13 papers), Chronic Myeloid Leukemia Treatments (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Ubiquitin and proteasome pathways (6 papers), Acute Myeloid Leukemia Research (6 papers), Heat shock proteins research (5 papers), MicroRNA in disease regulation (4 papers) and Cell death mechanisms and regulation (4 papers). The work is most often cited by research in Hematology (682 citations), Molecular Biology (3.1k citations) and Cancer Research (483 citations). Purva Bali has collaborated with scholars based in United States, Switzerland and India. Frequent co-authors include Kapil N. Bhalla, Fei Guo, Peter Atadja, Paul J. Kenny, Warren Fiskus, Heh‐In Im, Jonathan A. Hollander, Maria E. Balasis, Kathy Rocha and Michael Pranpat.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact